Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Tariq Aslam, EURETINA 2019 – AI in the ophthalmology practice

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 16th 2019

Tariq Aslam (Manchester Royal Eye Hospital, Manchester, UK) talks about the potential impact of deep learning algorithms, and the key challenges we face to bridge the gap to clincal application.

Questions:
1. What impact have deep learning algorithms had to date in the field of ophthalmology? 0:04
2. What are the major limitations of currently available fundus cameras and OCT devices? 1:01
3. What are the main take-home messages of your presentation ‘Beyond deep learning’? 1:50
4. What further research is needed before AI is used in the ophthalmology clinic? 2:42

Funding: No funding was received in the production of this video.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup